Astellas Pharma Europe Selects PAREXEL's Technology Subsidiary
Published on:
Applied Clinical Trials
PAREXEL International Corporation a today announced that its technology subsidiary Perceptive Informatics, Inc. has been selected by Astellas Pharma Europe Limited
BOSTON, May 22 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) today announced that its technology subsidiary Perceptive Informatics, Inc. has been selected by Astellas Pharma Europe Limited (http://www.astellas.com/eu) to supply its clinical trial management system (CTMS).
Advertisement
In a review of 10 vendors, Astellas Pharma Europe Limited selected Perceptive's IMPACT(TM) software to replace all of its existing CTMS systems, integrate with the company's other system applications, and to enable Astellas Pharma Europe Limited more efficient management of its clinical development programs.
